Daniel Winthrop Fisher

Daniel Fisher practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Daniel Fisher's NPI, 1740727734, was assigned on January 27, 2017. Daniel Fisher holds Washington license MD61196130.

Daniel Fisher's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Daniel Fisher's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Daniel Fisher is also affiliated with Swedish First Hill Campus. The medical group on file is UW Physicians. Dmand AI also links Daniel Fisher to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Fisher practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Daniel Fisher's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Daniel Fisher is licensed in Washington.

CMS data shows 173 Medicare services from Daniel Fisher across 6 procedure codes in 2024, for 80 Medicare patients. Medicare paid $15,554 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Daniel Fisher in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have alzheimer's and dementia, and 71% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Daniel Fisher's median patient age at 75, with 59% women.

In 2024, Daniel Fisher wrote 355 Medicare Part D claims for 51 patients. 97% of them were for generic drugs. CMS names the drug for 270 of them, across 7 drugs with 11 or more claims each, at $6,613 in total drug cost. In 2023, CMS named 59 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Daniel Fisher for performance year 2024, reported through an alternative payment model (APM). Daniel Fisher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Daniel Fisher as offering telehealth.

Dmand AI links 23 papers to Daniel Fisher, published from 2017 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Alzheimer Disease, Mice, Inbred C57BL and Mice, Transgenic. Daniel Fisher has published most often in J Neuroinflammation. Daniel Fisher's most frequent co-authors are David A. Bennett, MD, Bradford Clark Dickerson, MD and Mark C. Eldaief, MD.

CMS Open Payments shows 1 general payment to Daniel Fisher from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $84.